WIP1 dephosphorylation of p27^Kip1 Serine 140 destabilizes p27^Kip1 and reverses anti-proliferative effects of ATM phosphorylation

References

• Smith J, Tho LM, Xu N, et al. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73–112.
   PubMed Web of Science ®Google Scholar
• Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66:801–817.
   PubMed Web of Science ®Google Scholar
• Hanawalt PC. Historical perspective on the DNA damage response. DNA Repair (Amst). 2015;36:2–7.
   PubMed Web of Science ®Google Scholar
• Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14:197–210.
   Web of Science ®Google Scholar
• Morgan SE, Kastan MB. p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res. 1997;71:1–25.
   PubMed Web of Science ®Google Scholar
• Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998;281:1674–1677.
   PubMed Web of Science ®Google Scholar
• Canman CE, Lim DS, Cimprich KA, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 1998;281:1677–1679.
   PubMed Web of Science ®Google Scholar
• Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413–431.
   PubMed Web of Science ®Google Scholar
• Kastenhuber ER, Lowe SW. Putting p53 in context. Cell. 2017;170:1062–1078.
   PubMed Web of Science ®Google Scholar
• Wasylishen AR, Lozano G. Attenuating the p53 pathway in human cancers: many means to the same end. Cold Spring Harb Perspect Med. 2016; ;6(8).
   Web of Science ®Google Scholar
• Moyer SM, Larsson CA, Lozano G. Mdm proteins: critical regulators of embry ogenesis and homeostasis. J Mol Cell Biol. 2017;9:16–25.
   Web of Science ®Google Scholar
• Fiscella M, Zhang H, Fan S, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A. 1997;94:6048–6053.
   PubMed Web of Science ®Google Scholar
• Lu X, Nguyen TA, Moon SH, et al. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev. 2008;27:123–135.
   PubMed Web of Science ®Google Scholar
• Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 2005;19:1162–1174.
   PubMed Web of Science ®Google Scholar
• Lu X, Ma O, Nguyen TA, et al. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell. 2007;12:342–354.
   PubMed Web of Science ®Google Scholar
• Bulavin DV, Demidov ON, Saito S, et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet. 2002;31:210–215.
   PubMed Web of Science ®Google Scholar
• Rauta J, Alarmo EL, Kauraniemi P, et al. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat. 2006;95:257–263.
   PubMed Web of Science ®Google Scholar
• Coombs CC, Zehir A, Devlin SM, et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017;21:374–82 e4.
   PubMed Web of Science ®Google Scholar
• Hsu JI, Dayaram T, Tovy A, et al. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell. 2018;23:700–13 e6.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312–317.
   PubMed Web of Science ®Google Scholar
• Cassimere EK, Mauvais C, Denicourt C. p27Kip1 is required to mediate a G1 cell cycle arrest downstream of ATM following genotoxic stress. PLoS One. 2016;11:e0162806.
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8:253–267.
   PubMed Web of Science ®Google Scholar
• Bencivenga D, Caldarelli I, Stampone E, et al. p27(Kip1) and human cancers: A reappraisal of a still enigmatic protein. Cancer Lett. 2017;403:354–365.
   PubMed Web of Science ®Google Scholar
• Payne SR, Zhang S, Tsuchiya K, et al. p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol. 2008;28:258–268.
   PubMed Web of Science ®Google Scholar
• Cuadrado M, Gutierrez-Martinez P, Swat A, et al. p27Kip1 stabilization is essential for the maintenance of cell cycle arrest in response to DNA damage. Cancer Res. 2009;69:8726–8732.
   PubMed Web of Science ®Google Scholar
• Berton S, Cusan M, Segatto I, et al. Loss of p27(kip1) increases genomic instability and induces radio-resistance in luminal breast cancer cells. Sci Rep. 2017;7:595.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316:1160–1166.
   PubMed Web of Science ®Google Scholar
• Lowe J, Cha H, Lee MO, et al. Regulation of the Wip1 phosphatase and its effects on the stress response. Front Biosci (Landmark Ed). 2012;17:1480–1498.
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Durell SR, Chatterjee DK, et al. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. Biochemistry. 2007;46:12594–12603.
   PubMed Web of Science ®Google Scholar
• Lu X, Bocangel D, Nannenga B, et al. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell. 2004;15:621–634.
   PubMed Web of Science ®Google Scholar
• Gilmartin AG, Faitg TH, Richter M, et al. Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction. Nat Chem Biol. 2014;10:181–187.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Peng Y, et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet. 2002;31:133–134.
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Onishi N, Kato N, et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 2006;13:1170–1180.
   PubMed Web of Science ®Google Scholar
• Moon SH, Lin L, Zhang X, et al. Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J Biol Chem. 2010;285:12935–12947.
   PubMed Web of Science ®Google Scholar
• Denicourt C, Dowdy SF. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 2004;18:851–855.
   PubMed Web of Science ®Google Scholar
• Nguyen TA, Slattery SD, Moon SH, et al. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair. DNA Repair (Amst). 2010;9:813–823.
   PubMed Web of Science ®Google Scholar
• Moon SH, Nguyen TA, Darlington Y, et al. Dephosphorylation of gamma-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle. 2010;9:2092–2096.
   PubMed Web of Science ®Google Scholar
• Richter M, Dayaram T, Gilmartin AG, et al. WIP1 phosphatase as a potential therapeutic target in neuroblastoma. PLoS One. 2015;10:e0115635.
   PubMed Web of Science ®Google Scholar